Sino Biopharmaceutical Ltd - Total Other Income Expense Net

Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.

The item "Total-Other-Income-Expense-Net" stands at 1.50 Billion Hong Kong Dollars for the trailing twelve months (TTM) period ending 06/30/2025, the highest value since 12/31/2022.

Sino Biopharmaceutical Ltd's second quarter result of 1.10 Billion HKD for the item "Total Other Income Expense Net" represents no change compared to it's first quarter result.

Also, Sino Biopharmaceutical Ltd's second quarter result of 1.10 Billion HKD for the item "Total Other Income Expense Net" represents an increase of 22,076.79 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sino Biopharmaceutical Ltd's second quarter result of 1.50 Billion HKD for the item "Total Other Income Expense Net" represents an increase of 270.47 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 1.49 Billion Hong Kong Dollars compared to the value the year prior.
The 1 year change is 1.49 Billion Hong Kong Dollars.
The 3 year change is -4.54 Billion Hong Kong Dollars.
The 5 year change is 1.09 Billion Hong Kong Dollars.
The 10 year change is 1.02 Billion Hong Kong Dollars.

The Serie's long term average value is 1.61 Billion Hong Kong Dollars. It's latest available value, on 06/30/2025, is -0.104 Billion Hong Kong Dollars lower, compared to it's long term average value.
The Serie's change in Hong Kong Dollars from it's minimum value, on 06/30/2023, to it's latest available value, on 06/30/2025, is +2.39 Billion.
The Serie's change in Hong Kong Dollars from it's maximum value, on 12/31/2021, to it's latest available value, on 06/30/2025, is -11.86 Billion.